AIM - AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript
2024-04-02 11:32:08 ET
AIM ImmunoTech Inc. (AIM)
Q4 2023 Earnings Conference Call
April 2, 2024, 8:30 AM ET
Company Participants
Thomas Equels - Chief Executive Officer
Dr. Christopher McAleer - Scientific Officer
Conference Call Participants
James Molloy - Alliance Global Partners
Ed Woo - Ascendiant Capital Markets
Presentation
Operator
Hello. And welcome to the AIM ImmunoTech Fiscal Year 2023 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode. [Operator Instructions] Following the presentation will be a question-and-answer session. Note that this webcast is being recorded at the company’s request and a replay will be made available on the company’s website following the end of the event.
At this time, I’d like to remind our listeners that remarks made during this webcast may state management’s intentions, beliefs, expectations or future projections. These are forward-looking statements and involve risks and uncertainties.
Forward-looking statements on this call are made pursuant to the Safe Harbor provisions of the federal securities laws and are based on AIM’s current expectations, and actual results could differ materially. As a result, you should not place undue reliance on any forward-looking statements....
AIM ImmunoTech Inc. (AIM) Q4 2023 Earnings Call Transcript